1. Home
  2. POCI vs PLUR Comparison

POCI vs PLUR Comparison

Compare POCI & PLUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Precision Optics Corporation Inc.

POCI

Precision Optics Corporation Inc.

HOLD

Current Price

$4.21

Market Cap

32.6M

Sector

Health Care

ML Signal

HOLD

Logo Pluri Inc.

PLUR

Pluri Inc.

HOLD

Current Price

$3.01

Market Cap

31.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
POCI
PLUR
Founded
1982
2001
Country
United States
Israel
Employees
N/A
N/A
Industry
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
32.6M
31.5M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
POCI
PLUR
Price
$4.21
$3.01
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$12.00
AVG Volume (30 Days)
11.4K
48.1K
Earning Date
02-12-2026
02-10-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$21,575,039.00
$1,326,000.00
Revenue This Year
N/A
$97.38
Revenue Next Year
N/A
$293.97
P/E Ratio
N/A
N/A
Revenue Growth
13.67
121.74
52 Week Low
$3.77
$2.82
52 Week High
$5.34
$7.13

Technical Indicators

Market Signals
Indicator
POCI
PLUR
Relative Strength Index (RSI) 42.88 41.32
Support Level $4.13 $2.90
Resistance Level $4.25 $3.02
Average True Range (ATR) 0.12 0.23
MACD 0.00 0.01
Stochastic Oscillator 39.32 13.10

Price Performance

Historical Comparison
POCI
PLUR

About POCI Precision Optics Corporation Inc.

Precision Optics Corp Inc is engaged in designing, developing, and manufacturing advanced optical instruments. It manufactures medical products such as endoscopes and endocouplers which incorporate various optical technologies for use in a variety of minimally invasive surgical and diagnostic procedures. The company also produces endoscopes for various applications as well as designs and manufactures custom optical medical devices to satisfy customers' specific requirements. In addition, the company manufactures and sells components and assemblies specially designed for industrial and military use. The company earns the majority of its revenue from the United States.

About PLUR Pluri Inc.

Pluri Inc is a biotechnology company engaged in the research, development, and manufacturing of cell-based products, as well as the commercialization of cell therapeutics and related technologies aimed at delivering solutions across a range of industries, including regenerative medicine, immunotherapy, food tech, CDMO, and AgTech. The company uses its 3D cell expansion technology platform to develop placenta-based cell therapy product candidates (PLX-PAD and PLX-R18) for the treatment of inflammatory, muscle injuries, and hematologic conditions. In addition, it offers CDMO services through PluriCDMO, has launched a novel immunotherapy platform, and is engaged in developing cultivated, cell-cultured coffee and meat.

Share on Social Networks: